Published in Hepatitis Weekly, August 19th, 1996
Interferon alpha (IFN-(alpha)) has been shown to be effective in some patients with hepatitis C virus (HCV) disease. Although it is known that IFN-(alpha) can reduce HCV RNA levels, the exact manner of immunoregulation is not known.
"T lymphocytes and immunoregulatory cytokines may be important in the host response to HCV infection," researcher Thomas V. Cacciarelli and colleagues wrote ("Immunoregulatory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.